Esmee Koedoot

448 total citations
16 papers, 281 citations indexed

About

Esmee Koedoot is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Esmee Koedoot has authored 16 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Esmee Koedoot's work include RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (3 papers). Esmee Koedoot is often cited by papers focused on RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers) and Cancer Genomics and Diagnostics (3 papers). Esmee Koedoot collaborates with scholars based in Netherlands, United States and Canada. Esmee Koedoot's co-authors include Bob van de Water, Sylvia E. Le Dévédec, John W.M. Martens, Marcel Smid, Steven Wink, John A. Foekens, Jan Willem van der Laan, Bas ter Braak, Christine L. E. Siezen and Peter Stoilov and has published in prestigious journals such as Nature Communications, Cancer Research and Scientific Reports.

In The Last Decade

Esmee Koedoot

12 papers receiving 279 citations

Peers

Esmee Koedoot
Sócrates Villegas‐Comonfort Mexico
Kyung‐Min Yang South Korea
Peizhi Fan China
Madhura Bhagwat United States
Elisa Ferrari Italy
Jielin Yan United States
Dan‐ni Ren China
Yudan Xie China
Hui Ren China
Joanna Kałafut Poland
Sócrates Villegas‐Comonfort Mexico
Esmee Koedoot
Citations per year, relative to Esmee Koedoot Esmee Koedoot (= 1×) peers Sócrates Villegas‐Comonfort

Countries citing papers authored by Esmee Koedoot

Since Specialization
Citations

This map shows the geographic impact of Esmee Koedoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esmee Koedoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esmee Koedoot more than expected).

Fields of papers citing papers by Esmee Koedoot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esmee Koedoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esmee Koedoot. The network helps show where Esmee Koedoot may publish in the future.

Co-authorship network of co-authors of Esmee Koedoot

This figure shows the co-authorship network connecting the top 25 collaborators of Esmee Koedoot. A scholar is included among the top collaborators of Esmee Koedoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esmee Koedoot. Esmee Koedoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Wensink, G. Emerens, Carla S. Veríssimo, Esmee Koedoot, et al.. (2024). Organoids as a biomarker for personalized treatment in metastatic colorectal cancer: drug screen optimization and correlation with patient response. Journal of Experimental & Clinical Cancer Research. 43(1). 61–61. 26 indexed citations
4.
Veríssimo, Carla S., G. Emerens Wensink, Esmee Koedoot, et al.. (2023). Abstract 151: Optimization of screening conditions using patient-derived organoids for diagnostic purposes. Cancer Research. 83(7_Supplement). 151–151.
5.
Pont, Chantal, Esmee Koedoot, Anne Timmermans, et al.. (2022). A kinase inhibitor screen reveals MEK1/2 as a novel therapeutic target to antagonize IGF1R-mediated antiestrogen resistance in ERα-positive luminal breast cancer. Biochemical Pharmacology. 204. 115233–115233. 4 indexed citations
6.
Koedoot, Esmee, Marcel Smid, Peter Stoilov, et al.. (2021). Differential reprogramming of breast cancer subtypes in 3D cultures and implications for sensitivity to targeted therapy. Scientific Reports. 11(1). 7259–7259. 28 indexed citations
7.
Koedoot, Esmee, Román González‐Prieto, Alfred C.O. Vertegaal, et al.. (2021). Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention. Journal of Experimental & Clinical Cancer Research. 40(1). 82–82. 29 indexed citations
8.
Koedoot, Esmee, Marcel Smid, Hans de Bont, et al.. (2019). Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genes. Nature Communications. 10(1). 2983–2983. 60 indexed citations
9.
Koedoot, Esmee, Marcel Smid, John A. Foekens, et al.. (2019). Co-regulated gene expression of splicing factors as drivers of cancer progression. Scientific Reports. 9(1). 5484–5484. 22 indexed citations
10.
Nair, Nishanth Ulhas, Avinash Das, Richard Marcotte, et al.. (2019). Migration rather than proliferation transcriptomic signatures are strongly associated with breast cancer patient survival. Scientific Reports. 9(1). 10989–10989. 24 indexed citations
11.
Koedoot, Esmee, et al.. (2019). Splicing regulatory factors in breast cancer hallmarks and disease progression. Oncotarget. 10(57). 6021–6037. 20 indexed citations
12.
Koedoot, Esmee, Sylvia E. Le Dévédec, & Bob van de Water. (2017). Abstract 893: Systematic assessment of spliceosome components as drivers of breast cancer progression. Cancer Research. 77(13_Supplement). 893–893.
13.
Hiemstra, Steven, Marije Niemeijer, Esmee Koedoot, et al.. (2016). Comprehensive Landscape of Nrf2 and p53 Pathway Activation Dynamics by Oxidative Stress and DNA Damage. Chemical Research in Toxicology. 30(4). 923–933. 27 indexed citations
14.
Braak, Bas ter, Christine L. E. Siezen, Ewoud N. Speksnijder, et al.. (2015). Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/+WAPCre mouse model. Breast Cancer Research. 17(1). 14–14. 20 indexed citations
15.
Braak, Bas ter, Steven Wink, Esmee Koedoot, et al.. (2015). Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells. Breast Cancer Research. 17(1). 97–97. 6 indexed citations
16.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sócrates Villegas‐Comonfort Breakdown of academic impact, for papers by Kyung‐Min Yang Breakdown of academic impact, for papers by Peizhi Fan Breakdown of academic impact, for papers by Madhura Bhagwat Breakdown of academic impact, for papers by Elisa Ferrari Breakdown of academic impact, for papers by Jielin Yan Breakdown of academic impact, for papers by Dan‐ni Ren Breakdown of academic impact, for papers by Yudan Xie Breakdown of academic impact, for papers by Hui Ren Breakdown of academic impact, for papers by Joanna Kałafut
Rankless by CCL
2026